Brandon Folkes
Stock Analyst at H.C. Wainwright
(0.26)
# 4,601
Out of 5,090 analysts
555
Total ratings
36.8%
Success rate
-3.6%
Average return
Main Sectors:
Stocks Rated by Brandon Folkes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PYPD PolyPid | Reiterated: Buy | $13 | $5.39 | +141.19% | 12 | Oct 29, 2026 | |
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $7 | $0.8022 | +772.60% | 22 | Oct 28, 2026 | |
| DERM Journey Medical | Reiterated: Buy | $13 | $5.17 | +151.45% | 11 | Oct 26, 2026 | |
| ACHV Achieve Life Sciences | Reiterated: Buy | $12 | $6.83 | +75.70% | 15 | Oct 23, 2026 | |
| SGMT Sagimet Biosciences | Reiterated: Buy | $29 | $9.92 | +192.34% | 14 | Oct 22, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | $15.40 | $9.52 | +61.81% | 21 | Oct 20, 2026 | |
| OMER Omeros | Reiterated: Buy | $33 | $18.44 | +78.96% | 27 | Oct 16, 2026 | |
| RANI Rani Therapeutics Holdings | Reiterated: Buy | $11 | $0.59 | +1,764.41% | 13 | Oct 6, 2026 | |
| ENTA Enanta Pharmaceuticals | Reiterated: Buy | $20 | $10.71 | +86.74% | 13 | Sep 23, 2026 | |
| ANIP ANI Pharmaceuticals | Reiterated: Buy | $121 | $72.00 | +68.06% | 24 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $23.80 | +152.10% | 42 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.73 | +995.89% | 17 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $3.50 | +185.71% | 26 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.67 | +1,094.03% | 10 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.03 | +191.26% | 21 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $13.56 | +76.99% | 15 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12.57 | $1.62 | +675.81% | 15 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $5.45 | +230.28% | 10 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $10.71 | -6.63% | 9 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $10.28 | +152.92% | 16 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.296 | +237.84% | 5 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.2777 | - | 40 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $5.70 | +128.27% | 13 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $9.40 | +538.30% | 7 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.70 | +488.24% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $35.37 | +35.71% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $7.07 | n/a | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 → $16 | $6.81 | n/a | 29 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $4 | $2.28 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $10 | $0.8371 | n/a | 2 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 3 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $37 → $33 | $0.95 | n/a | 18 | Mar 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $15 | $2.19 | n/a | 15 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $282.55 | n/a | 1 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $40 | $0.3878 | n/a | 2 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.0003 | n/a | 1 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $50 | $0.0111 | n/a | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 → $32 | $45.34 | n/a | 12 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $25 | $49.37 | n/a | 3 | Nov 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $210 | $215.98 | n/a | 10 | Oct 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $8 | $0.000001 | n/a | 4 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $32.83 | n/a | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $12 | - | n/a | 9 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $33 | $21.23 | n/a | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $30 | $38.88 | n/a | 2 | Sep 12, 2016 |
PolyPid
Oct 29, 2026
Reiterated: Buy
Price Target: $13
Current: $5.39
Upside: +141.19%
Connect Biopharma Holdings
Oct 28, 2026
Reiterated: Buy
Price Target: $7
Current: $0.8022
Upside: +772.60%
Journey Medical
Oct 26, 2026
Reiterated: Buy
Price Target: $13
Current: $5.17
Upside: +151.45%
Achieve Life Sciences
Oct 23, 2026
Reiterated: Buy
Price Target: $12
Current: $6.83
Upside: +75.70%
Sagimet Biosciences
Oct 22, 2026
Reiterated: Buy
Price Target: $29
Current: $9.92
Upside: +192.34%
Eupraxia Pharmaceuticals Inc.
Oct 20, 2026
Reiterated: Buy
Price Target: $15.40
Current: $9.52
Upside: +61.81%
Omeros
Oct 16, 2026
Reiterated: Buy
Price Target: $33
Current: $18.44
Upside: +78.96%
Rani Therapeutics Holdings
Oct 6, 2026
Reiterated: Buy
Price Target: $11
Current: $0.59
Upside: +1,764.41%
Enanta Pharmaceuticals
Sep 23, 2026
Reiterated: Buy
Price Target: $20
Current: $10.71
Upside: +86.74%
ANI Pharmaceuticals
Sep 21, 2026
Reiterated: Buy
Price Target: $121
Current: $72.00
Upside: +68.06%
Sep 21, 2026
Reiterated: Buy
Price Target: $60
Current: $23.80
Upside: +152.10%
Sep 21, 2026
Reiterated: Buy
Price Target: $8
Current: $0.73
Upside: +995.89%
Sep 21, 2026
Reiterated: Buy
Price Target: $10
Current: $3.50
Upside: +185.71%
Sep 21, 2026
Reiterated: Buy
Price Target: $8
Current: $0.67
Upside: +1,094.03%
Sep 21, 2026
Reiterated: Buy
Price Target: $3
Current: $1.03
Upside: +191.26%
Sep 21, 2026
Reiterated: Buy
Price Target: $24
Current: $13.56
Upside: +76.99%
Sep 21, 2026
Reiterated: Buy
Price Target: $12.57
Current: $1.62
Upside: +675.81%
Sep 21, 2026
Reiterated: Buy
Price Target: $18
Current: $5.45
Upside: +230.28%
Sep 21, 2026
Reiterated: Buy
Price Target: $10
Current: $10.71
Upside: -6.63%
Sep 21, 2026
Reiterated: Buy
Price Target: $26
Current: $10.28
Upside: +152.92%
Aug 18, 2026
Reiterated: Hold
Price Target: $1
Current: $0.296
Upside: +237.84%
Aug 17, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.2777
Upside: -
Aug 14, 2026
Reiterated: Buy
Price Target: $13
Current: $5.70
Upside: +128.27%
Aug 14, 2026
Reiterated: Buy
Price Target: $60
Current: $9.40
Upside: +538.30%
Aug 13, 2026
Reiterated: Buy
Price Target: $10
Current: $1.70
Upside: +488.24%
Aug 4, 2026
Reiterated: Buy
Price Target: $48
Current: $35.37
Upside: +35.71%
Nov 14, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $7.07
Upside: n/a
Aug 22, 2024
Initiated Coverage: Buy
Price Target: $23 → $16
Current: $6.81
Upside: n/a
May 3, 2024
Reiterated: Buy
Price Target: $3 → $4
Current: $2.28
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $20 → $10
Current: $0.8371
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 13, 2023
Reiterated: Hold
Price Target: $37 → $33
Current: $0.95
Upside: n/a
Feb 9, 2023
Reiterated: Buy
Price Target: $22 → $15
Current: $2.19
Upside: n/a
Feb 3, 2023
Reiterated: Buy
Price Target: $48
Current: $282.55
Upside: n/a
Nov 22, 2022
Reiterated: Buy
Price Target: $22 → $40
Current: $0.3878
Upside: n/a
Nov 2, 2022
Initiated Coverage: Buy
Price Target: $5
Current: $0.0003
Upside: n/a
Mar 31, 2022
Reiterated: Buy
Price Target: $5 → $50
Current: $0.0111
Upside: n/a
Jan 27, 2022
Upgraded: Buy
Price Target: $22 → $32
Current: $45.34
Upside: n/a
Nov 4, 2021
Reiterated: Buy
Price Target: $23 → $25
Current: $49.37
Upside: n/a
Oct 6, 2021
Reiterated: Buy
Price Target: $210
Current: $215.98
Upside: n/a
Aug 9, 2021
Reiterated: Buy
Price Target: $6 → $8
Current: $0.000001
Upside: n/a
Jun 30, 2021
Initiated Coverage: Buy
Price Target: $45
Current: $32.83
Upside: n/a
May 6, 2021
Reiterated: Buy
Price Target: $18 → $12
Current: -
Upside: n/a
Dec 15, 2020
Reiterated: Buy
Price Target: $25 → $33
Current: $21.23
Upside: n/a
Sep 12, 2016
Reiterated: Buy
Price Target: $34 → $30
Current: $38.88
Upside: n/a